TrialDiabetes care2015

Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).

Francesco Giorgino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.